Research Article | Volume: 5, Issue: 11, November, 2015

Tumor Necrosis Factor Receptor 2: Its Clinical Significance and Clinicopathologic Correlation in acute leukemias

Nabila El Kramani Nehal M Elsherbiny Amal M El-Gayar Mohamed A. Ebrahim Mohammed M H Al-Gayyar   

Open Access   

Published:  Nov 27, 2015

DOI: 10.7324/JAPS.2015.501113
Abstract

Objectives: To measure plasma concentrations of Tumor Necrosis Factor Receptor 2 (TNFR2) in patients with acute leukemia, and to correlate the results with clinical features.

Material and Methods: Twenty-four patients with acute myeloid leukemia (AML), sixteen patients with acute lymphoblastic leukemia (ALL) and fifteen control subjects were included in the current study. TNFR2 was measured in plasma of all subjects by enzyme-linked immunosorbent assay.

Results: Plasma TNFR2 significantly increased in ALL compared to both control and AML cases.

Conclusions: TNFR2 may be used as a biomarker for differentiating between AML and ALL patients.


Keyword:     Tumor Necrosis Factor Receptor 2 Acute leukemia Myeloid Lymphoblastic.


Citation:

El Kramani N, Elsherbiny NM, El-Gayar AM, Ebrahim MA, AlGayyar MMH. Tumor Necrosis Factor Receptor 2: Its Clinical Significance and Clinicopathologic Correlation in acute leukemias. J App Pharm Sci, 2015; 5 (11): 079-083.

Copyright:The Author(s). This is an open access article distributed under the Creative Commons Attribution Non-Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

HTML Full Text

Reference

Article Metrics
353 Views 15 Downloads 368 Total

Year

Month

Related Search

By author names